PR

Profound Medical Corp. (PRN)

TSX

Currency in CAD
9.42
-0.06 (-0.63%)

Closed

Aug 25, 2026

Day's Range

9.31
9.84

52 wk Range

5.23
12.40

Profile - PRN - Profound Medical Corp.

Profile

Mic Code

XTSE

Sector

Healthcare

Industry

Medical Devices

Employees

162


Profound Medical Corp. is a pioneering company in the medical technology sector, specializing in the development of innovative therapeutic platforms for treating prostate issues, breast cancer, and uterine fibroids. The core function of Profound Medical Corp. is to provide minimally invasive therapeutic solutions, leveraging its proprietary technologies to improve patient outcomes and enhance the efficacy of treatments. The company's proprietary TULSA-PRO and SONALLEVE systems integrate ultrasound imaging with precise ablation capabilities, offering non-invasive options for patients. These technologies are particularly significant in the healthcare sector as they aim to reduce recovery time, lower the risk of complications, and improve overall treatment experiences. By focusing on areas such as oncology and men’s health, Profound Medical Corp. plays a crucial role in advancing medical treatments and improving the quality of life for patients. The company's innovations are poised to impact hospitals, clinics, and specialized medical facilities globally, marking a significant advancement in non-surgical therapeutic strategies."

Profile Details

Type

Common Stock

Ceo

Dr. Arun Swarup Menawat MBA, Ph.D.

Address

2400 Skymark Avenue

City

Mississauga

State

ON

Zip

L4W 5K5

Country

Canada

Phone

647 476 1350

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Stocks news

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.